Visit Foundation Medicine at ASCO 2016

| May 17, 2016

header-asco2016-v2

Foundation Medicine will be exhibiting at Booth #24109 during the meeting with over 20 poster presentations and 2 oral presentations at #ASCO16. No doubt that genomic profiling, immunotherapy and liquid biopsy are going to have a huge presence at ASCO and Foundation Medicine is actively involved bringing patient-centric technologies to market for targeted therapies.

Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.

Foundation Medicine is helping the cancer community push the field of routine cancer care forward in the following ways:

Patients first. We bring a pan-cancer orientation to the treatment of both solid tumors and hematologic cancers, and help make precision medicine a reality for patients by providing comprehensive genomic profiles to oncologists to help them match their patients to targeted therapies.

Research. We collaborate with drug developers and cancer researchers to identify novel targets and assist in the development of targeted cancer therapies and active clinical trials.

Data. We leverage our molecular information platform, using our growing knowledgebase of genomic information about human cancers and incorporating clinical data, to inform drug development and enable precision medicine.

For more information about Foundation Medicine’s activities, check out their dedicated web page with schedule of poster and oral presentations, schedule a meeting at their booth or RSVP for their social activities at http://www.foundationone.com/asco2016/. You can also follow them @FoundationATCG.
MasterHexagonDraft3_background2


Tags: , , , , ,

Category: Anatomic Pathology, Clinical Laboratories, Clinical Pathology, Conferences, Current Affairs, Education, Genetics, Laboratory Management & Operations, Liquid Biopsy, Marketing, Medical Research, Pathology News, Patient Advocacy, Science, Training

Comments are closed.